INDmoney
TEVA
Teva Pharmaceutical Industries Ltd Earnings
$30.47
Earnings Summary
Revenue | $4711Mn |
Net Profits | $480Mn |
Net Profit Margins | 10.19% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 11.4% since last year same period to $4711Mn in the Q4 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 5.16% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 321.2% since last year same period to $480Mn in the Q4 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 10.85% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 298.57% since last year same period to 10.19% in the Q4 2025. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 5.42% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.55 |
EPS Estimate Current Year | 0.55 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.55 - a -15.48% fall from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.55.
Key Ratios
Earning Per Share (EPS) | 0 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Teva Pharmaceutical Industries Ltd has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-13 | 0.55 | 0 | -100% |
